Literature DB >> 1080976

Profiles of antinuclear antibodies in systemic rheumatic diseases.

D D Notman, N Kurata, E M Tan.   

Abstract

The prevalence of different antinuclear antibodies was examined in systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, progressive systemic sclerosis, dermatomyositis, discoid lupus erythematosus, and mixed connective tissue disease. Antibody to Sm antigen (a nuclear acidic protein) was found almost exclusively in serums of patients with systemic lupus erythematosus, suggesting that this antibody might be a "marker" antibody for this disease. However, antibodies to native DNA and to nuclear ribonucleoprotein were found in a variety of systemic rheumatic diseases. In systemic lupus erythematosus, antibody to native DNA was present in high titer but in other rheumatic diseases in low titer. Antibody to nuclear ribonucleoprotein occurred in certain other systemic rheumatic diseases besides the mixed connective tissue disease syndrome. These studies showed that there were distinct profiles of antinuclear antibodies in certain systemic rheumatic diseases, characterized by the presence or absence of certain antibodies and by differences in their mean titers.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080976     DOI: 10.7326/0003-4819-83-4-464

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  79 in total

1.  Antibodies to extractable nuclear antigens. Has technological drift affected clinical interpretation?

Authors:  R J Lock; D J Unsworth
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

Review 2.  Anti-Sm autoantibodies in systemic lupus erythematosus mice: a model system for disease-specific autoreactivity.

Authors:  R A Eisenberg
Journal:  Springer Semin Immunopathol       Date:  1992

3.  Accelerated expression of anti-Sm and Y2 idiotype differ in dependence on T cell subsets in MRL/+ mice.

Authors:  M L Miller; H Dang; N Talal
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

4.  Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus.

Authors:  M L Boey; C L Peebles; G Tsay; P H Feng; E M Tan
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

5.  Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.

Authors:  B Combe; M Rucheton; H Graafland; V Lussiez; C Brunel; J Sany
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

6.  Lupus autoantibodies discriminate between the highly homologous Sm polypeptides B/B' and SmN by binding an epitope restricted to B/B'.

Authors:  J D Huntriss; D S Latchman; D G Williams
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

7.  Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome.

Authors:  Z M Sthoeger; B Tartakovsky; Z Bentwich; E Mozes
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

8.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

9.  Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice.

Authors:  R A Eisenberg; S Y Craven; R W Warren; P L Cohen
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

10.  Serological profile of rheumatoid arthritis in west Africa.

Authors:  A O Adebajo; P J Charles; B L Hazleman; R N Maini
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.